Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
DJ

David Y. Jackson — 19 Patents

Genentech: 9 patents #330 of 2,392Top 15%
BBBolt Biotherapeutics: 4 patents #3 of 10Top 30%
Stanford University: 3 patents #905 of 5,197Top 20%
MTMagenta Therapeutics: 2 patents #10 of 18Top 60%
S(Syntex (U.S.A.): 2 patents #260 of 599Top 45%
Hoffmann-La Roche: 1 patents #1,850 of 3,238Top 60%
Oakland, CA: #308 of 4,380 inventorsTop 8%
California: #31,067 of 386,348 inventorsTop 9%
Overall (All Time): #229,345 of 4,157,543Top 6%
19 Patents All Time
David Y. Jackson has been granted 19 US patents while listed as an inventor at Genentech. The first was granted in 1990 and the most recent in March 2024. David Y. Jackson ranks #229,345 of 4,157,543 US inventors in our database (top 5.5%). Patent records list David Y. Jackson in Oakland, CA, US.

Issued Patents All Time

Showing 1–19 of 19 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
11932695 Modified antibodies and related compounds, compositions and methods of use Edward Ha 2024-03-19
11547761 Antibody adjuvant conjugates Michael N. Alonso, Edgar G. Engleman, Shelley Erin Ackerman, Justin Kenkel, Arthur Lee 2023-01-10
11400164 Immunoconjugates targeting HER2 Shelley Erin Ackerman, Michael N. Alonso, Arthur Lee, Edgar G. Engleman 2022-08-02
11229711 Linkers for antibody-drug conjugates and related compounds, compositions, and methods of use Edward Ha 2022-01-25
11110178 Antibody adjuvant conjugates Michael N. Alonso, Edgar G. Engleman, Shelley Erin Ackerman, Justin Kenkel, Arthur Lee 2021-09-07
10781259 Modified antibodies and related compounds, compositions, and methods of use Edward Ha 2020-09-22
10675358 Antibody adjuvant conjugates Michael N. Alonso, Edgar G. Engleman, Shelley Erin Ackerman, Justin Kenkel, Arthur Lee 2020-06-09
7947839 Heterocyclic-substituted bis-1,8 naphthalimide compounds, antibody drug conjugates, and methods of use Lewis Gazzard, Edward Ha, Joann Um 2011-05-24
7595399 Tyrosine derivatives Frederick C. Sailes, Daniel P. Sutherlin 2009-09-29
7265146 Integrin receptor inhibitors Dean R. Artis, Thomas E. Rawson, Mark E. Reynolds, Daniel P. Sutherlin, Mark S. Stanley 2007-09-04 $102,427,000
7166600 Thiocarbamate inhibitors of alpha-4 integrins 2007-01-23 $92,306,000
7015323 Thiocarbamate inhibitors of alpha-4 integrins 2006-03-21 $703,189,000
6933314 Integrin receptor inhibitors Dean R. Artis, Thomas E. Rawson, Mark E. Reynolds, Daniel P. Sutherlin, Mark S. Stanley 2005-08-23 $329,163,000
6706753 Integrin receptor inhibitors Dean R. Artis, Thomas E. Rawson, Mark E. Reynolds, Daniel P. Sutherlin, Mark S. Stanley 2004-03-16 $717,249,000
6469047 Tyrosine derivatives Frederick C. Sailes, Daniel P. Sutherlin 2002-10-22 $45,152,000
6265572 Pyrrolidincarbonylamino cyclic disulfide anti-inflammatory agents Li Chen, Nader Fotouhi, Jefferson Wright Tilley 2001-07-24
5629173 Methods of use of serine protease variants having peptide ligase activity Lars Abrahmsen, John Burnier, James A. Wells 1997-05-13 $7,254,000
5248788 Process for preparing allenic prostanoic acid derivatives Gary F. Cooper, Colin C. Beard, Douglas L. Wren 1993-09-28 $16,125,000
4916238 Process for preparing allenic prostanoic acid derivatives Gary F. Cooper, Colin C. Beard, Douglas L. Wren 1990-04-10 $35,423,000